News
17h
Medical Device Network on MSNMedtronic’s defibrillation lead gains FDA approval for use in right ventricleThe US Food and Drug Administration (FDA) has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for ...
Medtronic (NYSE: MDT) announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle ...
The device is designed to lower blood pressure while simultaneously modulating the autonomic nervous system by delivering ...
Hospitals are aligning purchasing strategies accordingly. In Q1 and Q2 of 2024, biventricular pacemaker market leaders like Medtronic, Abbott, and Boston Scientific released AI-powered CRT devices ...
Another algorithm, available in Medtronic, Guidant, and Biotronik devices, initiates biventricular pacing on top of a ventricular-sensed event, and may allow resynchronization, assuming that ...
3d
TipRanks on MSNMedtronic receives FDA approval for OmniaSecure defibrillation leadMedtronic (MDT) received U.S. Food and Drug Administration approval for the OmniaSecure defibrillation lead for placement within the right ...
The human pacemaker Tara the miniature schnauzer received was donated to the canine by medical device company Medtronic Kelli Bender is the Pets Editor at PEOPLE. She has been working at PEOPLE ...
Christensen, Clayton M. "We've Got Rhythm! Medtronic Corp.'s Cardiac Pacemaker Business (TN)." Harvard Business School Teaching Note 698-056, March 1998.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results